Active substance
Meprobamate
- US FDA 57
- US price lines 2
- Safety 2
US FDA United States — FDA approvals (Drugs@FDA)
| Product | Strength | Form · route | Applicant | Status | First approved |
|---|---|---|---|---|---|
| MEPROBAMATE | 200MG; 400MG | tablet · oral | INVAGEN PHARMS | Prescription | 27 Feb 2008 |
| MEPROBAMATE | 200MG; 400MG | tablet · oral | ALEMBIC PHARMS LTD | Prescription | 18 Feb 2009 |
| MILTOWN | 400MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**; 200MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | tablet · oral | MEDPOINTE PHARM HLC | Discontinued | 28 Apr 1955 |
| EQUANIL | 400MG; 200MG | tablet · oral | WYETH AYERST | Discontinued | 26 Jul 1955 |
| NEURAMATE | 400MG; 200MG | tablet · oral | HALSEY | Discontinued | 3 Jul 1963 |
| MEPROBAMATE | 400MG; 200MG | tablet · oral | SANDOZ | Discontinued | 26 Jul 1963 |
| MEPROBAMATE | 400MG; 200MG | tablet · oral | CHARTWELL MOLECULAR | Discontinued | 9 Aug 1963 |
| MEPROBAMATE | 400MG | tablet · oral | MALLARD | Discontinued | 13 Apr 1964 |
| MEPROBAMATE | 400MG; 200MG | tablet · oral | WEST WARD | Discontinued | 12 Dec 1964 |
| TRANMEP | 400MG | tablet · oral | SOLVAY | Discontinued | 27 Jan 1967 |
| BAMATE | 200MG; 400MG | tablet · oral | ALRA | Discontinued | 29 Jul 1971 |
| MEPROBAMATE | 400MG | tablet · oral | RISING | Discontinued | 12 Jul 1972 |
| MEPROBAMATE | 200MG; 400MG | tablet · oral | SUN PHARM INDUSTRIES | Discontinued | 16 Oct 1972 |
| MEPROBAMATE | 200MG | tablet · oral | WATSON LABS | Discontinued | 23 Apr 1973 |
| MEPROBAMATE | 400MG | tablet · oral | WATSON LABS | Discontinued | 3 May 1973 |
| MEPROBAMATE | 400MG | tablet · oral | WHITEWORTH TOWN PLSN | Discontinued | 20 Dec 1973 |
| MILTOWN | 600MG | tablet · oral | MEDPOINTE PHARM HLC | Discontinued | 28 Jan 1974 |
| MEPROBAMATE | 200MG | tablet · oral | WHITEWORTH TOWN PLSN | Discontinued | 13 Feb 1974 |
| MEPROBAMATE | 600MG | tablet · oral | IVAX SUB TEVA PHARMS | Discontinued | 29 Apr 1974 |
| AMOSENE | 400MG | tablet · oral | FERNDALE LABS | Discontinued | 10 May 1974 |
| MEPROBAMATE | 400MG | tablet · oral | ACELLA | Discontinued | 3 Jul 1974 |
| MEPROBAMATE | 600MG | tablet · oral | BARR | Discontinued | 10 Jul 1974 |
| MEPROBAMATE | 200MG | tablet · oral | NEXGEN PHARMA INC | Discontinued | 30 Sep 1974 |
| MEPROBAMATE | 400MG | tablet · oral | NEXGEN PHARMA INC | Discontinued | 17 Apr 1975 |
| MEPROBAMATE | 200MG; 400MG | tablet · oral | PARKE DAVIS | Discontinued | 9 Dec 1975 |
32 more — full table
Prices — United States and England
| Source | Product as listed | Price | Unit / pack | Date |
|---|---|---|---|---|
| US NADAC | MEPROBAMATE 200 MG TABLET | $4.54257 | per EA | 23 Sep 2026 |
| US NADAC | MEPROBAMATE 400 MG TABLET | $5.89239 | per EA | 23 Sep 2026 |
NADAC: average price US retail pharmacies pay to buy the medicine. NHS Drug Tariff Part VIIIA: basic price reimbursed to pharmacies in England and Wales.
Safety signals and safety-related labeling changes
- US FDA 21 Nov 2024 EQUAGESIC — safety-related labeling change
Labeling sections changed: Warnings and Precautions; Adverse Reactions; Use in Specific Populations - MHRA 18 Apr 2016 Meprobamate: licence to be cancelled
Following an EU wide review of meprobamate, the remaining licence holder in the UK has ceased manufacturing and the licence will be cancelled by the end of 2016.
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.